Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
Open Access
- 1 September 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 4 (9) , 1378-1387
Abstract
Cell cycle regulators, such as the CDC25 phosphatases, are potential targets for the development of new anticancer drugs. Here we report the identification and the characterization of BN82685, a quinone-based CDC25 inhibitor that is active in vitro and in vivo. BN82685 inhibits recombinant CDC25A, B, and C phosphatases in vitro. It inhibits the growth of human tumor cell lines with an IC50 in the submicromolar range, independently of their resistance to chemotherapeutic agents. This inhibitory effect is irreversible on both the purified CDC25 enzyme in vitro and on tumor cell proliferation. The specificity of BN82685 towards the CDC25 phosphatases is shown by an increase in cyclin-dependent kinase 1 tyrosine 15 phosphorylation, by the reversion of the mitosis-inducing effect of CDC25B overexpression in HeLa cells, and by the lack of a growth inhibitory effect in an assay based on the use of a CDC25-independent fission yeast model. Finally, when administered p.o., BN82685 is shown to inhibit the growth of the human pancreatic tumor Mia PaCa-2 xenografted in athymic nude mice. BN82685 is therefore a promising new compound targeting CDC25, which confirms the interest of the inhibition of these enzymes as an anticancer therapeutic strategy.Keywords
This publication has 28 references indexed in Scilit:
- Ability of human CDC25B phosphatase splice variants to replace the function of the fission yeast Cdc25 cell cycle regulatorFEMS Yeast Research, 2004
- Evolutionary Conservation of a Novel Splice Variant of the Cds1/CHK2 Checkpoint Kinase Restricted to its Regulatory DomainCell Cycle, 2004
- Synthesis and biological evaluation of caulibugulones A–EOrganic & Biomolecular Chemistry, 2004
- Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2–M transitionJournal of Cell Science, 2004
- Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysisOncogene, 2004
- Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinomaOncogene, 2004
- Inhibition of Cdc25 Phosphatases by IndolyldihydroxyquinonesJournal of Medicinal Chemistry, 2003
- Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancerOncogene, 2003
- Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25CEuropean Journal of Cell Biology, 2000
- The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaksOncogene, 1999